Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc (AMLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amylyx Pharmaceuticals Inc 43 Thorndike St. Cambridge MA 02141 USA

P: 617-682-0917

Description:

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 2,485,925
Enterprise Value, $K 2,629,155
Shares Outstanding, K 66,256
Annual Sales, $ 290 K
Annual Net Income, $ -87,930 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -53,760 K
% of Insider Shareholders 12.70%
% of Institutional Shareholders 44.65%
Float, K 57,841
% Float 87.30%
Short Volume Ratio 0.54

Growth:

1-Year Return 106.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.92 on 11/10/22
Next Earnings Date N/A
Earnings Per Share ttm -2.78
EPS Growth vs. Prev Qtr 1.08%
EPS Growth vs. Prev Year 133.72%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 03/28/18
Dividend Payable Date 04/02/18
Dividend Payout Ratio 0.00%

AMLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -172.54%
Return-on-Assets % -93.56%
Profit Margin % -30,320.69
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 8,645.83
Price/Cash Flow N/A
Price/Book 17.10
Book Value/Share 2.17
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar